Yusuf              S., Reddy S., Ounpuu S. et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization // Circulation. -
- N. 104. - P. 2746-2753.
Maziak              W., Ward K.D., Stockton M.B Childhood obesity: are we missing the big picture? // Obes. Rev. - 2008. - Vol. 9. - P. 35-42.
Pierce              J.P. Tobacco industry marketing, population-based tobacco control, and smoking behavior // Am. J. Prev. Med. - 2007. - Vol. 33. - Suppl. 6. - P. 327-334.
Pell              J.P., Haw S., Cobbe S. et al. Smoke-free legislation and hospitalizations for acute coronary syndrome // N. Engl. J. Med. - 2008. - Vol. 359. - P. 482-491.
British              Heart Foundation. European Cardiovascular Disease Statistics 2008. - London: British Heart Foundation, 2008.
Kesteloot              H., Sans S., Kromhout D. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000 // Eur. Heart J. - 2007. - Vol. 27. - P. 107-113.
Muller-Nordhorn              J., Binting S., Roll S. et al. An update on regional variation in cardiovascular mortality within Europe // Eur. Heart J. - 2008. - Vol. 29. - P. 1316-1326.
Bjorck              L., Bennett R.A., Lappas K. et al. Modelling the Decreasing Coronary              Heart              Disease Mortality in
Sweden between 1986 and 2002 // Eur. Heart J. - 2009. - Vol. 30. - P. 1046-1056.
Bennett              K., Kabir Z., Unal B. et al. Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000 // J. Epidemiol. Community Health. - 2007. - Vol. 60. - P. 322-327.
Critchley              J., Liu J., Zhao D. et al. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999 // Circulation. - 2004. - Vol. 110. - P. 1236-1244.
.Ford E.S., Ajani U.A., Croft J.B. et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 // N. Engl. J. Med. - 2007. - Vol. 356. - P. 2388-2398.
Laatikainen              T., Critchley J., Vartiainen E. et al. Explaining the decline              in              coronary              heart disease
mortality in Finland between 1982 and 1997 // Am. J. Epidemiol. - 2005. - Vol. 162. - P. 764-773.
Unal              B., Critchley J.A., Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000 // Circulation. - 2004. - Vol. 109. - P. 1101-1107.
WHO.              World Health Report 2004. - Geneva: W.H.O., 2004.
Graham              I., Atar D., Borch-Johnsen K. et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) // Eur. J. Cardiovasc. Prev. Rehabil. - 2007. - 14. - Suppl. 2. - P. 1-113.
Pyorala              K., De Backer G, Graham I. et al. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension // Eur. Heart J. - 1994. - Vol. 15. - P. 1300-1331.
Anderson              K.M., Wilson P.W., Odell P.M. et al. An updated coronary risk profile. A statement for health professionals // Circulation. - 1991. - Vol. 83. - P. 356-362.
Conroy              R.M., Pyorala K., Fitzgerald A.P. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project // Eur. Heart J. - 2003. - Vol. 24. - P. 987-1003.
Clinical              reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group / European Action on Secondary Prevention by Intervention to Reduce Events // Lancet. - 2001. - Vol. 357. - P. 995-1001.
Lifestyle              and risk. factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme // Eur. Heart J. - 2001. - Vol. 22. - P. 554-572.
21 .Boersma E., Keil U., De Bacquer D. et al. Blood pressure is insufficiently controlled in European patients with established coronary heart disease // J. Hypertens. - 2003. - Vol. 21. - P. 1831-1840.
22.Scholte op Reimer W., de Swart E., De Bacquer D. et al. Smoking behaviour in European patients with established coronary heart disease // Eur. Heart J. - 2007. - Vol. 27. - P. 35-41.
Yusuf              S., Hawken S., Ounpuu S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study // Lancet. - 2004. - Vol. 364. - P. 937-952.
Pekka              P., Pirjo P., Ulla U. Influencing public nutrition for non-communicable disease prevention: from community intervention to national programme - experiences from Finland // Public. Health Nutr. - 2002. - Vol. 5(1A). - P. 245-251.
Lloyd-Jones              D.M., Larson M.G., Beiser A. et al. Lifetime risk of developing coronary heart disease // Lancet. - 1999. - Vol. 353. - P. 89-92.
McGill              H.C. Jr, McMahan C.A., Gidding S.S. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study // Circulation. - 2008. - Vol. 117. - P. 1216-1227.
Lerner              D.J., Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population // Am. Heart J. - 1986. - Vol. 111. - P. 383-390.
Kuh              D., Langenberg C., Hardy R. et al. Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study // BJOG. - 2005. - Vol. 112. - P. 476-485.
Grodstein              F., Manson J.E., Colditz G.A. et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease // Ann. Intern. Med. - 2000. -
Vol. 133. - P. 933-941.
Hulley              S., Grady D., Bush T. et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group // JAMA. - 1998. - Vol. 280. - P. 605-613.
.Manson J.E., Hsia J., Johnson K.C. et al. Estrogen plus progestin and the risk of coronary heart disease // N. Engl. J. Med. - 2003. - Vol. 349. - P. 523-534.
Manson              J.E., Bassuk S.S., Harman S.M. et al. Postmenopausal hormone therapy: new questions and the case for new clinical trials // Menopause. - 2007. - Vol. 13. - P. 139-147.
Lawlor              D.A., Ebrahim S., Davey Smith G. Sex matters: secular and geographical trends in sex differences in coronary heart disease mortality // BMJ. - 2001. - Vol. 323. - P. 541-545.
Thomsen              T.F., Davidsen M., Ibsen H. et al. A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score // J. Cardiovasc. Risk. - 2001. - Vol. 8. - P. 291-297.
Grover              S., Coupal L., Lowensteyn L. Preventing cardiovascular disease among Canadians: is the treatment of hypertension or dyslipidemia cost-effective? // Can. J. Cardiol. - 2008. - Vol. 24. - P. 891-898.
Dudas              K., Lappas G., Rosengren A. Trends in out-of-hospital deaths in Sweden. - Manuscript, 2009.
Jackson              R., Wells S., Rodgers A. Will screening individuals at high risk of cardiovascular events deliver large benefits? Yes. // BMJ. - 2008. - Vol. 337. - P. 1371.
Hellermann              J.P., Reeder G.S., Jacobsen S.J. et al. Longitudinal trends in the severity of acute myocardial infarction: a population study in Olmsted County, Minnesota // Am. J. Epidemiol. - 2002. - Vol. 156. - P. 246-253.
Teo              K.K., Ounpuu S., Hawken S. et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study // Lancet. - 2006. - Vol. 368. - P. 647-658.
Christakis              N.A., Fowler J.H. The collective dynamics of smoking in a large social network // N. Engl. J Med. - 2008. - Vol. 358. - P. 2249-2258.
41 .Kawachi I., Colditz G.A., Stampfer M.J. et al. Smoking cessation in relation to total mortality rates in women. A prospective cohort study // Ann. Intern. Med. - 1993. - Vol. 119. - P. 992-1000.
Howard              G., Wagenknecht L.E., Burke G.L. et al. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study // JAMA. - 1998. - Vol. 279. - P. 119-124.
Critchley              J., Capewell S. Smoking cessation for the secondary prevention of coronary heart disease // Cochrane Database Syst. Rev. - 2004. - Vol. 1. - CD003041.
Balfour              D., Benowitz N., Fagerstrom K. et al. Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report // Eur. Heart J. - 2000. - Vol. 21. - P. 438-445.
Fagerstrom              K.O., Schneider N.G. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire // J Behav Med. - 1989. - Vol. 12. - P. 159-182.
Lancaster              T., Stead L.F. Self-help interventions for smoking cessation // Cochrane Database Syst Rev. - 2005. - Vol. 3. - CD001118.
Lancaster              T., Stead L.F. Individual behavioural counselling for smoking cessation // Cochrane Database Syst. Rev. - 2002. - Vol. 3. - CD001292.
48.Stead L.F., Lancaster T. Group behaviour therapy programmes for smoking cessation // Cochrane Database Syst Rev. - 2002. - Vol. 3. - CD001007.
49.Stead L.F., Perera R., Bullen C. et al. Nicotine replacement therapy for smoking cessation // Cochrane Database Syst. Rev 2008. - Vol. 1. - CD000146.
50.Meine T.J., Patel M.R., Washam J.B. et al. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes // Am. J. Cardiol. - 2005. - Vol. 95. - P. 976-978.
51 .Hughes J.R., Stead L.F., Lancaster T. Antidepressants for smoking cessation // Cochrane Database Syst. Rev. - 2007. - Vol. 1. - CD000031.
Caspersen              C.J., Pereira M.A., Curran K.M. Changes in physical activity patterns in the United States, by sex and cross-sectional age // Med. Sci. Sports Exerc. - 2000. - Vol. 32. - P. 1601-1609.
Hillsdon              M., Foster C., Thorogood M. Interventions for promoting physical activity // Cochrane Database Syst. Rev. - 2005. - Vol. 1. - CD003180.
Boreham              C., Riddoch C. The physical activity, fitness and health of children // J. Sports Sci. - 2001. - Vol. 19. - P. 915-929.
McGill,              H.C. Jr, McMahan C.A., Zieske A.W. et al. Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth // Circulation. - 2000. - Vol. 102. - P. 374379.
Daniels              S.R. Cardiovascular disease risk factors and atherosclerosis in children and adolescents // Curr. Atheroscler. Rep. - 2001. - Vol. 3. - P. 479-485.
Morris              J.N., Heady J.A., Raffle P.A. et al. Coronary heart-disease and physical activity of work // Lancet. - 1953. - Vol. 265. - P. 1053-1057.
Paffenbarger              R.S. Jr, Laughlin M.E., Gima A.S. et al. Work activity of longshoremen as related to death from coronary heart disease and stroke // N. Engl. J. Med. - 1970. - Vol. 282. - P. 1109-1114.
Blair              S.N., Kohl H.W., 3rd, Barlow C.E. et al. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men // JAMA. - 1995. - Vol. 273. - P. 1093-1098.
Myers              J., Prakash M., Froelicher V. et al. Exercise capacity and mortality among men referred for exercise testing // N. Engl. J. Med. - 2002. - Vol. 346. - P. 793-801.
61 .Rosengren, A., Wilhelmsen L. Physical activity protects against coronary death and deaths from all causes in middle-aged men. Evidence from a 20-year follow-up of the primary prevention study in Goteborg // Ann. Epidemiol. - 1997. - Vol. 7. - P. 69-75.
Mittleman              M.A., Maclure M., Tofler G.H. et al. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators // N. Engl. J. Med. - 1993. - Vol. 329. - P. 1677-1683.
Leaf              D.A., Kleinman M.T., Hamilton M. et al. The exercise-induced oxidative stress paradox: the effects of physical exercise training // Am. J. Med. Sci. - 1999. - Vol. 317. - P. 295-300.
Malfatto              G., Facchini M., Sala L. et al. Effects of cardiac rehabilitation and beta-blocker therapy on heart rate variability after first acute myocardial infarction // Am. J. Cardiol. - 1998. - Vol. 81. - P. 834-840.
Niebauer,              J., Hambrecht R., Velich T. et al. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise // Circulation. - 1997. - Vol. 96. - P. 25342541.
Jolliffe              J.A., Rees K., Taylor R.S. et al. Exercise-based rehabilitation for coronary heart disease // Cochrane Database Syst. Rev. - 2001. - Vol. 1. - CD001800.
Piepoli              M.F., Davos C., Francis D.P. et al. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) // BMJ. - 2004. - Vol. 328. - P. 189.
68.Sirard J.R. Pate RR. Physical activity assessment in children and adolescents // Sports Med. - 2001. - Vol. 31. - P. 439-454.
Craig              C.L., Marshall A.L., Sjostrom M. et al. International physical activity questionnaire: 12-country reliability and validity // Med. Sci. Sports Exerc. - 2003. - Vol. 35. - P. 1381-1395.
Giannuzzi              P., Mezzani A., Saner H. et al. Physical activity for primary and secondary prevention. Position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology // Eur. J. Cardiovasc. Prev. Rehabil. - 2003. - Vol. 10. - P. 319-327.
Fletcher,              G.F., Balady G.J., Amsterdam E.A. et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association // Circulation. - 2001. - Vol. 104. - P. 1694-1740.
Haskell              W.L., Lee I.M., Pate R.R. et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association // Med. Sci. Sports Exerc. - 2007. - Vol. 39. - P. 1423-1434.
Borg              G.A. Psychophysical bases of perceived exertion // Med. Sci. Sports Exerc. - 1982. - Vol. 14. - P. 377-381.
Mbalilaki              J.A., Masesa Z., Stromme S.B. et al. Daily energy expenditure and cardiovascular risk in Masai, rural and urban Bantu Tanzanians // Br. J. Sports Med. - 2008.
Williams              M.A., Haskell W.L., Ades P.A. et al. Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism // Circulation. - 2007. - Vol. 116. - P. 572-584.
Thompson              P.D., Franklin B.A., Balady G.J. et al. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology // Circulation. - 2007. -
Vol. 115. - P. 2358-2368.
Nelson              M.E., Rejeski W.J., Blair S.N. et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association // Med. Sci. Sports Exerc. - 2007. - Vol. 39. - P. 1435-1445.
Aggarwal              A., Ades P.A. Exercise rehabilitation of older patients with cardiovascular disease // Cardiol Clin. - 2001. - Vol. 19. - P. 525-536.
Lewington              S., Clarke R., Qizilbash N. et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies // Lancet. -
- Vol. 360. - P. 1903-1913.
Beilin              L.J., Burke V., Cox K.L. et al. Non pharmacologic therapy and lifestyle factors in hypertension // Blood Press. - 2001. - Vol. 10. - P. 352-365.
.Beilin L.J. Update on lifestyle and hypertension control // Clin. Exp. Hypertens. - 2004. - Vol. 26. - P. 739-746.
Vasan              R.S., Larson M.G., Leip E.P. et al. Impact of high-normal blood pressure on the risk of cardiovascular disease // N. Engl. J. Med. - 2001. - Vol. 345. - P. 1291-1297.
Hooper              L., Summerbell C.D., Higgins J.P. et al. Dietary fat intake and prevention of cardiovascular disease: systematic review // BMJ. - 2001. - Vol. 322. - P. 757-763.
Hu              F.B., Stampfer M.J., Manson J.E. et al. Dietary fat intake and the risk of coronary heart disease in women // N. Engl. J. Med. - 1997. - Vol. 337. - P. 1491-1499.
Kushi              L.H., Lew R.A., Stare F.J. et al. Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart Study // N. Engl. J. Med. - 1985. - Vol. 312. - P. 811-818.
Judd              J.T., Clevidence B.A., Muesing R.A. et al. Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women // Am. J. Clin. Nutr. - 1994. - Vol. 59. - P. 861-868.
Mozaffarian              D., Willett W.C. Trans fatty acids and cardiovascular risk: a unique cardiometabolic imprint? // Curr. Atheroscler. Rep. - 2007. - Vol. 9. - P. 486-493.
Hu              F.B., Willett W.C. Optimal diets for prevention of coronary heart disease // JAMA. - 2002. - Vol. 288. - P. 2569-2578.
Hu              F.B., Bronner L., Willett W.C. et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women // JAMA. - 2002. - Vol. 287. - P. 1815-1821.
Jenkins,              D.J., Josse A.R., Dorian P. et al. Heterogeneity in randomized controlled trials of long chain (fish) omega-3 fatty acids in restenosis, secondary prevention and ventricular arrhythmias // J Am Coll Nutr. - 2008. - Vol. 27. - P. 367-378.
Mozaffarian              D., Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits // JAMA. - 2007. - Vol. 296. - P. 1885-1899.
92.Sacks F.M., Svetkey L.P., Vollmer W.M. et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group // N. Engl. J. Med. - 2001. - Vol. 344. - P. 3-10.
Dauchet L., Amouyel P., Dallongeville J. Fruit and vegetable consumption and risk of stroke: a metaanalysis of cohort studies // Neurology. - 2005. - Vol. 65. - P. 1193-1197.
Dauchet              L., Amouyel P., Hercberg S. et al. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies // J. Nutr. - 2007. - Vol. 136. - P. 2588-2593.
Vivekananthan              D.P., Penn M.S., Sapp S.K. et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials // Lancet. - 2003. - Vol. 361. - P. 2017-2023.
Rehm              J.T., Bondy S.J., Sempos C.T. et al. Alcohol consumption and coronary heart disease morbidity and mortality // Am. J. Epidemiol. - 1997. - Vol. 146. - P. 495-501.
Rimm              E.B., Klatsky A., Grobbee D. et al. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits // BMJ. - 1996. - Vol. 312. - P. 731-736.
Forte              J.G., Miguel J.M., Miguel M.J. et al. Salt and blood pressure: a community trial // J. Hum. Hypertens. - 1989. - Vol. 3. - P. 179-184.
99.Shai I., Schwarzfuchs D., Henkin Y. et al. Weight loss with a low-carbohydrate, Mediterranean, or low- fat diet // N. Engl. J. Med. - 2008. - Vol. 359. - P. 229-241.
100.Sofi F., Cesari F., Rosanna A. et al. Adherence to Mediterranean diet and health status: metaanalysis // BMJ. - 2008. - Vol. 337. - P. 1344.
Christakis              N.A., Fowler J.H. The spread of obesity in a large social network over 32 years // N Engl J. Med. - 2007. - Vol. 357. - P. 370-379.
Mitchell              R.T., McDougall C.M., Crum J.E. Decreasing prevalence of obesity in primary schoolchildren // Arch. Dis. Child. - 2007. - Vol. 92. - P. 153-154.
103.Sjoberg A., Lissner L., Albertsson-Wikland K. et al. Recent anthropometric trends among Swedish school children: evidence for decreasing prevalence of overweight in girls // Acta. Paediatr. - 2008. - Vol. 97. - P. 118-123.
104.Sundblom E., Petzold M., Rasmussen F. et al. Childhood overweight and obesity prevalences levelling off in Stockholm but socioeconomic differences persist // Int. J. Obes. (Lond). - 2008. - Vol. 32. - P. 1525-1530.
Barrett-Connor              E.L. Obesity, atherosclerosis, and coronary artery disease // Ann. Intern. Med. - 1985. - Vol. 103. - P. 1010-1019.
Jousilahti              P., Tuomilehto J., Vartiainen E. et al. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland // Circulation. - 1996. - Vol. 93. - P. 1372-1379.
Rexrode              K.M., Carey V.J., Hennekens C.H. et al. Abdominal adiposity and coronary heart disease in women // JAMA. - 1998. - Vol. 280. - P. 1843-1848.
Yusuf              S., Hawken S., Ounpuu S. et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study // Lancet. - 2005. - Vol. 366. - P. 1640-1649.
Kortelainen              M.L., Sarkioja T. Visceral fat and coronary pathology in male adolescents // Int. J. Obes. Relat. Metab. Disord. - 2001. - Vol. 25. - P. 228-232.
McGill              H.C. Jr, McMahan C.A., Herderick E.E. et al. Obesity accelerates the progression of coronary atherosclerosis in young men // Circulation. - 2002. - Vol. 105. - P. 2712-2718.
Kannel              W.B., D’Agostino R.B., Cobb J.L. Effect of weight on cardiovascular disease // Am. J. Clin. Nutr. - 1996. - Vol. 63. - Suppl. 3. - P. 419-422.
112.Shaper A.G., Wannamethee S.G., Walker M. Body weight: implications for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men // BMJ. - 1997. - Vol. 314. - P. 1311-1317.
Grundy              S.M. Obesity, metabolic syndrome, and cardiovascular disease // J. Clin. Endocrinol.
Metab. - 2004. - Vol. 89. - P. 2595-2600.
Third              Report. of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report // Circulation. - 2002. - Vol. 106. - P. 3143-3421.
Alberti              K.G., Zimmet P., Shaw J. The metabolic syndrome - a new worldwide definition // Lancet. - 2005. - Vol. 366. - P. 1059-1062.
Ford              E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey // JAMA. - 2002. - Vol. 287. - P. 356-359.
Christensen R., Kristensen P.K., Bartels E.M. et al. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials // Lancet. - 2007. - Vol. 370. - P. 1706-1713.
118.Sjostrom L., Narbro K., Sjostrom C.D. et al. Effects of bariatric surgery on mortality in Swedish obese subjects // N. Engl. J. Med. - 2007. - Vol. 357. - P. 741-752.
119.Durrington P. Dyslipidaemia // Lancet. - 2003. - Vol. 362. - P. 717-731.
120.Sharrett A.R., Ballantyne C.M., Coady S.A. et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study // Circulation. - 2001. - Vol. 104. - P. 1108-1113.
Verschuren              W.M., Jacobs D.R., Bloemberg B.P. et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study // JAMA. - 1995. - Vol. 274. - P. 131-16.
Chen              Z., Peto R., Collins R. et al. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations // BMJ. - 1991. - Vol. 303. - P. 276-282.
Njolstad              I., Arnesen E., Lund-Larsen P.G. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study // Circulation. - 1996. - Vol. 93. - P. 450-456.
Assmann              G., Gotto A.M. Jr. HDL cholesterol and protective factors in atherosclerosis // Circulation. -
- Vol. 109. - III. - P. 8-14.
Hokanson              J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies // J. Cardiovasc. Risk. - 1996. - Vol. 3. - P. 213-219.
McQueen              M.J., Hawken S., Wang X. et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study // Lancet. - 2008. - Vol. 372. - P. 224-233.
WHO              cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators // Lancet. - 1980. - Vol. 2. - P. 379-385.
Randomised              trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) // Lancet. - 1994. - Vol. 344. - P. 1383-1389.
MRC/BHF              Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial // Lancet. - 2002. - Vol. 360. - P. 7-22.
130.Shepherd J., Cobbe S.M., Ford I. et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group // N. Engl. J. Med. - 1995. - Vol. 333. - P. 1301-1307.
Baigent              C., Keech A., Kearney P.M. et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins // Lancet. -
- Vol. 366. - P. 1267-1278.
Ridker              P.M., Danielson E., Fonseca F.A. et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein // N. Engl. J. Med. - 2008. - Vol. 359. - P. 2195-2207.
Lewington              S., Whitlock G., Clarke R. et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths // Lancet. - 2007. - Vol. 370. - P. 1829-1839.
Jousilahti              P., Vartiainen E., Tuomilehto J. et al. Twenty-year dynamics of serum cholesterol levels in the middle-aged population of eastern Finland // Ann. Intern. Med. - 1996. - Vol. 125. - P. 713-722.
Rosengren              A., Dotevall A., Eriksson H. et al. Optimal risk factors in the population: prognosis, prevalence, and secular trends; data from Goteborg population studies // Eur. Heart J. - 2001. - Vol. 22. - P. 136-144.
Josan              K., Majumdar S.R., McAlister F.A. The efficacy and safety of intensive statin therapy: a metaanalysis of randomized trials // CMAJ. - 2008. - Vol. 178. - P. 576-584.
Rubins              H.B., Robins S.J., Collins D. et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group // N. Engl. J. Med. - 1999. - Vol. 341. - P. 410-418.
138.138. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study // Circulation. - 2000. - Vol. 102. - P. 21-27.
Hemingway              H., Marmot M. Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies // BMJ. - 1999. - Vol. 318. - P. 1460-1467.
Rozanski              A., Blumenthal J.A., Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy // Circulation. - 1999. - Vol. 99. - P. 2192-2217.
Kuper              H., Marmot M., Hemingway H. Systematic review of prospective cohort studies of psychosocial factors in the etiology and prognosis of coronary heart disease // Semin. Vasc. Med. - 2002. - Vol. 2. -
P. 267-314.
Rosengren              A., Hawken S., Ounpuu S. et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study // Lancet. - 2004. - Vol. 364. - P. 953-962.
Macleod              J., Metcalfe C., Smith G.D. et al. Does consideration of either psychological or material disadvantage improve coronary risk prediction? Prospective observational study of Scottish men // J Epidemiol Community Health. - 2007. - Vol. 61. - P. 833-837.
Lee              S., Colditz G., Berkman L. et al. A prospective study of job strain and coronary heart disease in US women // Int. J. Epidemiol. - 2002. - Vol. 31. - P. 1147-1153; discussion 1154.
Matthews              K.A., Gump B.B. Chronic work stress and marital dissolution increase risk of posttrial mortality in men from the Multiple Risk Factor Intervention Trial // Arch. Intern. Med. - 2002. - Vol. 162. - P. 309-315.
146.Iso H., Date C., Yamamoto A. et al. Perceived mental stress and mortality from cardiovascular disease among Japanese men and women: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk Sponsored by Monbusho (JACC Study) // Circulation. - 2002. - Vol. 106. - P. 1229-1236.
Kivimaki              M., Leino-Arjas P., Luukkonen R. et al. Work stress and risk of cardiovascular mortality: prospective cohort study of industrial employees // BMJ. - 2002. - Vol. 325. - P. 857.
Rosengren              A., Tibblin G., Wilhelmsen L. Self-perceived psychological stress and incidence of coronary artery disease in middle-aged men // Am. J. Cardiol. - 1991. - Vol. 68. - P. 1171-15.
Macleod              J., Smith G.D., Heslop P. et al. Are the effects of psychosocial exposures attributable to confounding? Evidence from a prospective observational study on psychological stress and mortality // J. Epidemiol. Community Health. - 2001. - Vol. 55. - P. 878-884.
Macleod              J., Davey Smith G. et al. Psychological stress and cardiovascular disease: empirical demonstration of bias in a prospective observational study of Scottish men // BMJ. - 2002. - Vol. 324. - P. 1247-1251.
Furlan              R., Barbic F., Piazza S. et al. Modifications of cardiac autonomic profile associated with a shift schedule of work // Circulation. - 2000. - Vol. 102. - P. 1912-1916.
Tenkanen              L., Sjoblom T., Kalimo R. et al. Shift work, occupation and coronary heart disease over 6 years of follow-up in the Helsinki Heart Study // Scand. J. Work Environ. Health. - 1997. - Vol. 23. -
P. 257-265.
153.Orth-Gomer K., Wamala S.P., Horsten M. et al. Marital stress worsens prognosis in women with coronary heart disease: The Stockholm Female Coronary Risk Study // JAMA. - 2000. - Vol. 284. - P. 3008-3014.
Rugulies              R. Depression as a predictor for coronary heart disease. a review and meta-analysis // Am. J. Prev. Med. - 2002. - Vol. 23. - P. 51-61.
Barth              J., Schumacher M., Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis // Psychosom. Med. - 2004. - Vol. 66. - P. 802-813.
Horsten              M., Mittleman M.A., Wamala S.P. et al. Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk Study // Eur. Heart J. - 2000. - Vol. 21. - P. 1072-1080.
Kaplan              G.A, Keil J.E. Socioeconomic factors and cardiovascular disease: a review of the literature // Circulation. - 1993. - Vol. 88. - 4 Pt 1. - P. 1973-1998.
Braveman              P.A., Cubbin C., Egerter S. et al. Socioeconomic status in health research: one size does not fit all // JAMA. - 2005. - Vol. 294. - P. 2879-2888.
Lynch              J., Davey Smith G, Harper S. et al. Explaining the social gradient in coronary heart disease: comparing relative and absolute risk approaches // J. Epidemiol. Community Health. - 2007. - Vol. 60. - P. 436-441.
Yarnell              J., Yu S., McCrum E. et al. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME
Study // Int. J. Epidemiol. - 2005. - Vol. 34. - P. 268-275.
Kunst              A.E., Groenhof F., and Mackenbach JP. Mortality by occupational class among men 30-64 years in 11 European countries.
EU Working Group on Socioeconomic Inequalities in Health // Soc. Sci. Med. - 1998. - Vol. 46. - P. 14591476.
Woodward              M., Brindle P., Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) // Heart. - 2007. - Vol. 93. - P. 172-176.
Kaplan              J.R., Pettersson K., Manuck S.B. et al. Role of sympathoadrenal medullary activation in the initiation and progression of atherosclerosis // Circulation. - 1991. - Vol. 84. - V. - P. 123-132.
164.Strawn W.B., Bondjers G., Kaplan J.R. et al. Endothelial dysfunction in response to psychosocial stress in monkeys // Circ. Res. - 1991. - Vol. 68. - P. 1270-1279.
Kop              W.J., Krantz D.S., Howell R.H. et al. Effects of mental stress on coronary epicardial vasomotion and flow velocity in coronary artery disease: relationship with hemodynamic stress responses // J. Am. Coll. Cardiol. - 2001. - Vol. 37. - P. 1359-1366.
Ghiadoni              L., Donald A.E., Cropley M. et al. Mental stress induces transient endothelial dysfunction in humans // Circulation. - 2000. - Vol. 102. - P. 2473-2478.
Marmot,              M.G, Shipley M.J., Hemingway H. et al. Biological and behavioural explanations of social inequalities in coronary heart disease: the Whitehall II study // Diabetologia. - 2008. - Vol. 51. - P. 19801988.
von              Kanel R, Mills P.J., Fainman C. et al // Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom. Med. - 2001. - Vol. 63. - P. 531-544.
Rees              K., Bennett P., West R. et al. Psychological interventions for coronary heart disease // Cochrane Database Syst. Rev. - 2004. - Vol. 2. - CD002902.
Dusseldorp              E., van Elderen T, Maes S. et al. A meta-analysis of psychoeduational programs for coronary heart disease patients // Health Psychol. - 1999. - Vol. 18. - P. 506-519.
Linden              W., Phillips M.J., Leclerc J. Psychological treatment of cardiac patients: a meta-analysis // Eur. Heart J. - 2007. - Vol. 28. - P. 2972-2984.
van              Dixhoorn J, White A. Relaxation therapy for rehabilitation and prevention in ischaemic heart disease: a systematic review and meta-analysis // Eur. J. Cardiovasc. Prev. Rehabil. - 2005. - Vol. 12. - P. 193-202.
van              Melle J.P., de Jonge P., Honig A. et al. Effects of antidepressant treatment following myocardial infarction // Br. J. Psychiatry. - 2007. - Vol. 190. - P. 460-466.
Glassman              A.H., O’Connor C.M., Califf R.M. et al. Sertraline treatment of major depression in patients with acute MI or unstable angina // JAMA. - 2002. - Vol. 288. - P. 701-709.
Anand              S.S., Islam S., Rosengren A. et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study // Eur. Heart J. - 2008. - Vol. 29. - P. 932-940.